These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27033172)

  • 1. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study.
    Ebrahimi H; Emamian MH; Hashemi H; Fotouhi A
    Diabetes Metab Syndr; 2016; 10(3):149-56. PubMed ID: 27033172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The magnitude of type 2 diabetes mellitus and cardiovascular disease risk factors among young adults in urban settings: a cross-sectional survey in Mwanza, Tanzania.
    Malindisa EK; Balandya E; Mashili F; Iddi S; Njelekela M
    Pan Afr Med J; 2022; 42():19. PubMed ID: 35812257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
    Ali N; Samadder M; Kathak RR; Islam F
    PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia.
    Esteghamati A; Meysamie A; Khalilzadeh O; Rashidi A; Haghazali M; Asgari F; Kamgar M; Gouya MM; Abbasi M
    BMC Public Health; 2009 May; 9():167. PubMed ID: 19480675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.
    Abera A; Worede A; Hirigo AT; Alemayehu R; Ambachew S
    Eur J Med Res; 2024 Apr; 29(1):237. PubMed ID: 38622622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.
    Sun GZ; Li Z; Guo L; Zhou Y; Yang HM; Sun YX
    Lipids Health Dis; 2014 Dec; 13():189. PubMed ID: 25496459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia, obesity and other cardiovascular risk factors in the adult population in Senegal.
    Doupa D; Seck SM; Dia CA; Diallo FA; Kane MO; Kane A; Gueye PM; Mbaye MN; Gueye L; Jobe M
    Pan Afr Med J; 2014; 19():181. PubMed ID: 25815102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in northern China: a cross-sectional study.
    Xi Y; Niu L; Cao N; Bao H; Xu X; Zhu H; Yan T; Zhang N; Qiao L; Han K; Hang G; Wang W; Zhang X
    BMC Public Health; 2020 Jul; 20(1):1068. PubMed ID: 32631296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
    Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
    Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
    Pan L; Yang Z; Wu Y; Yin RX; Liao Y; Wang J; Gao B; Zhang L;
    Atherosclerosis; 2016 May; 248():2-9. PubMed ID: 26978581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population.
    Sharifi F; Mousavinasab SN; Soruri R; Saeini M; Dinmohammadi M
    Metab Syndr Relat Disord; 2008 Sep; 6(3):187-95. PubMed ID: 18774906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modifiable noncommunicable risk factors among an Iranian population.
    Shirani S; Heidari K; Sabzghabaee AM; Mirmoghtadaee P; Hoseini L; Aalifar H; Fadaei H; Esnaashari H; Soltani R
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1227-32. PubMed ID: 23431831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IDEA study (International Day for the Evaluation of Abdominal Obesity): primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia].
    Ruiz ÁJ; Aschner PJ; Puerta MF; Cristancho RA
    Biomedica; 2012; 32(4):610-6. PubMed ID: 23715236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey.
    Nikparvar M; Khaladeh M; Yousefi H; Vahidi Farashah M; Moayedi B; Kheirandish M
    Sci Rep; 2021 Apr; 11(1):9125. PubMed ID: 33911149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project.
    Wietlisbach V; Marques-Vidal P; Kuulasmaa K; Karvanen J; Paccaud F;
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):432-42. PubMed ID: 22209742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia and associated risk factors in a resettlement colony of Delhi.
    Sharma U; Kishore J; Garg A; Anand T; Chakraborty M; Lali P
    J Clin Lipidol; 2013; 7(6):653-60. PubMed ID: 24314364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.